Transcat (TRNS) Earning Somewhat Favorable News Coverage, Accern Reports

Media stories about Transcat (NASDAQ:TRNS) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Transcat earned a news impact score of 0.01 on Accern’s scale. Accern also assigned media headlines about the scientific and technical instruments company an impact score of 45.649087290141 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of Transcat stock traded up $0.05 on Friday, hitting $15.25. 1,030 shares of the stock were exchanged, compared to its average volume of 3,517. The company has a market cap of $109.08, a price-to-earnings ratio of 22.43, a price-to-earnings-growth ratio of 2.72 and a beta of 0.39. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.38. Transcat has a 52-week low of $11.60 and a 52-week high of $16.49.

How to Become a New Pot Stock Millionaire

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.09. The firm had revenue of $40.48 million for the quarter. Transcat had a net margin of 3.24% and a return on equity of 10.03%. sell-side analysts expect that Transcat will post 0.7 earnings per share for the current fiscal year.

A number of brokerages have recently weighed in on TRNS. Zacks Investment Research raised shares of Transcat from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Saturday, February 3rd. Roth Capital began coverage on shares of Transcat in a research note on Friday, February 9th. They set a “buy” rating and a $20.00 target price on the stock. Finally, Singular Research lifted their target price on shares of Transcat from $15.30 to $20.00 and gave the company a “buy” rating in a research note on Monday, February 5th.

In other news, Director John T. Smith sold 2,000 shares of Transcat stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $15.70, for a total transaction of $31,400.00. Following the sale, the director now owns 33,100 shares of the company’s stock, valued at approximately $519,670. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 8.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Transcat (TRNS) Earning Somewhat Favorable News Coverage, Accern Reports” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3299257/transcat-trns-earning-somewhat-favorable-news-coverage-accern-reports.html.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Lexington Realty Trust  Hits New 1-Year High and Low at $7.62
Lexington Realty Trust Hits New 1-Year High and Low at $7.62
Eyes Lips Face  Reaches New 52-Week High and Low at $17.14
Eyes Lips Face Reaches New 52-Week High and Low at $17.14
Contrasting Finish Line  & Foot Locker
Contrasting Finish Line & Foot Locker
Comparing Aeglea Bio Therapeutics  & Aileron Therapeutics
Comparing Aeglea Bio Therapeutics & Aileron Therapeutics
AerCap  and The Competition Head to Head Analysis
AerCap and The Competition Head to Head Analysis
Intesa Sanpaolo  Given Average Rating of “Buy” by Analysts
Intesa Sanpaolo Given Average Rating of “Buy” by Analysts


© 2006-2018 Ticker Report. Google+.